Reversible effects of photodamage directed toward mitochondria

Area of Science:

• Biochemistry
• Cell Biology
• Photomedicine

Background:

• Photodynamic therapy (PDT) is a treatment modality that uses photosensitizers and light to induce cell death.
• Mitochondria are key targets in PDT, and their photodamage leads to early cellular events.
• Loss of mitochondrial membrane potential (ΔΨm) is a critical early indicator of mitochondrial dysfunction.

Purpose of the Study:

• To investigate the relationship between mitochondrial photodamage, loss of mitochondrial membrane potential (ΔΨm), apoptosis, and cell viability in murine hepatoma cells following PDT.
• To determine if the early loss of ΔΨm can serve as a reliable predictor of photodynamic therapy efficacy.

Main Methods:

• Murine hepatoma 1c1c7 cells were treated with a mitochondria-targeting photosensitizer and exposed to varying light doses.
• The potential-sensitive probe Mitotracker Orange (MTO) was used to detect changes in mitochondrial membrane potential (ΔΨm).
• Apoptosis and cell viability were assessed over time in response to PDT.

Main Results:

• A rapid decrease in ΔΨm was observed, correlating with loss of cell viability.
• However, loss of ΔΨm was found to be reversible even when cells showed significant loss of viability.
• Cells could recover their mitochondrial membrane potential unless subjected to supralethal photodamage, even if initiating apoptosis.

Conclusions:

• Mitochondrial membrane potential (ΔΨm) loss is an early and sensitive indicator of PDT-induced mitochondrial damage.
• The reversibility of ΔΨm loss highlights the dynamic nature of mitochondrial response to PDT.
• Assessing the initial loss of ΔΨm provides a valuable qualitative estimate of photokilling when mitochondria are the primary PDT target.